Birmingham Cancer Patient Shares Life-Changing Impact of New Drug Amivantamab Monday, June 1, 2026 amivantamab cancer headandneck clinicaltrial tumourreduction oncology immunotherapy monoclonalantibody chemotherapy icr A groundbreaking clinical trial led by the Institute of Cancer Research (ICR) in London has revealed “unprecedentedly strong responses” to a new injectable drug, amivantamab, which has eliminated entire tumors in … Read More